Edition:
United Kingdom

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (1349.HK)

1349.HK on Hong Kong Stock

3.87HKD
21 May 2018
Change (% chg)

HK$0.01 (+0.26%)
Prev Close
HK$3.86
Open
HK$3.85
Day's High
HK$3.87
Day's Low
HK$3.80
Volume
171,000
Avg. Vol
565,761
52-wk High
HK$6.23
52-wk Low
HK$3.17

Latest Key Developments (Source: Significant Developments)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Posts ‍FY Profit Attributable Of RMB75.3 Million
Friday, 23 Mar 2018 

March 23 (Reuters) - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd <1349.HK>::‍FY REVENUE RMB497.7 MILLION VERSUS RMB621.9 MILLION.‍FY PROFIT ATTRIBUTABLE RMB75.3 MILLION VERSUS RMB138.7 MILLION​.BOARD RECOMMENDED PAYMENT OF FINAL DIVIDEND OF RMB0.03 PER ORDINARY SHARE.  Full Article

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical subscribes for RMB60 mln in Shanghai BVCF's fund
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Shanghai Fudan-zhangjiang Bio-pharmaceutical Co Ltd <1349.HK>::Subscribed for RMB60 million in Shanghai BVCF's ‍BVCF fund.  Full Article

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical says HY revenue rmb272 million
Friday, 4 Aug 2017 

Aug 4 (Reuters) - Shanghai Fudan-zhangjiang Bio-pharmaceutical Co Ltd <1349.HK>::HY revenue rmb272 million versus rmb241.9 million.HY profit attributable to shareholders of company of approximately rmb49.6 million versus about rmb45.9 million​.  Full Article

Shanghai Fudan-zhangjiang Bio-pharmaceutical Co clarifies on negative rumors about co
Tuesday, 20 Jun 2017 

June 20 (Reuters) - Shanghai Fudan-zhangjiang Bio-pharmaceutical Co Ltd <1349.HK>:Received enquiries from investors and noticed negative rumors focusing on forecast of interim results of co.Confirmed rumors released without any prior verification or authorization & not reflects actual situation.Co has not published any information in relation to interim results of co for six months ended 30 june 2017.  Full Article

Shanghai Fudan-Zhangjiang Bio-pharma unit obtained drug approval
Monday, 17 Oct 2016 

Shanghai Fudan-zhangjiang Bio-pharmaceutical Co Ltd <1349.HK>:Shanghai fudan-zhangjiang bio-pharmaceutical - unit as obtained drug approval issued by china fda for hemoporfin for injection.  Full Article